MedLink Neurology: The Information Resource for Clinical Neurology

Home Contents

MedLink Neurology Editorial Board

(Click to view former Editorial Board members.)

Editor-In-Chief

Raymond P Roos MD*
Marjorie and Robert E. Straus Professor in Neurological Science
Professor of Neurology
University of Chicago Medical Center
Editorial Board Member since 2001: Neuroimmunology
*Chair, Executive Committee

Disclosures: Dr. Roos serves on the Scientific Advisory Board of Revalesio Corporation and a Drug Monitoring Board for a gene therapy study of Sarepta Therapeutics. He has also received consulting fees from Best Doctors and Guidepoint Network, and holds shares in Amgen, Merck, Ionis, and Express Scripts.

Senior Associate Editors

	Emma Ciafaloni MD FAAN Robert C. and Rosalyne H. Griggs Professor in Experimental Therapeutics of Neurologic Disease Professor of Neurology, Pediatrics, Obstetrics, and Gynecology Director Pediatric Neuromuscular Medicine University of Rochester Rochester, New York Editorial Board Member since 2017: Neuromuscular Disorders Disclosures: Dr. Ciafaloni received personal compensation for serving on advisory boards and/or as a consultant for Avexis, Biogen, Pfizer, PTC Therapeutics, Sarepta, Ra pharma, Wave, and Strongbridge Biopharma; and for serving on a speaker’s bureau for Biogen. Dr Ciafaloni also received research and/or grant support from Orphazyme, PTC Therapeutics, Santhera, and Sarepta.
	Antonio Culebras MD FAAN FAHA FAASM* Professor of Neurology SUNY Upstate Medical University Sleep Center, Upstate University Hospital at Community General Syracuse, New York Founding Editorial Board Member since 1994: Sleep Disorders *Member, Executive Committee Disclosures: Dr. Culebras received an honorariums from Jazz Pharmaceuticals for a speaking engagements.
	Darryl De Vivo MD Sidney Carter Professor of Neurology and Pediatrics Co-Director, Motor Neuron Center Associate Chairman for Pediatric Neurosciences and Developmental Neurobiology Founding Director of the Colleen Giblin Research Laboratories for Pediatric Neurology Columbia University Founding Editorial Board Member 1995-2009, Emeritus since 2009: Childhood Metabolic Disorders Disclosures: Dr. De Vivo has no relevant financial relationships to disclose.
	Salvatore DiMauro MD Lucy G Moses Professor of Neurology Director Emeritus of H. Houston Merritt Clinical Research Center for the Study of Muscular Dystrophy and Related Diseases Associate Chair for Laboratory Research and Training Columbia University Founding Editorial Board Member since 1992, Emeritus since 2017: Neuromuscular Disorders Disclosures: Dr. DiMauro has no relevant financial relationships to disclose.
	Edward Dropcho MD Professor of Neurology Indiana University Editorial Board Member since 2008: Neuro-Oncology Disclosures: Dr. Dropcho has no relevant financial relationships to disclose.
	Jerome Engel Jr MD PhD Professor of Neurology, Neurobiology, and Psychiatry & Biobehavioral Sciences David Geffen School of Medicine University of California, Los Angeles Founding Editorial Board Member since 1992: Epilepsy Disclosures: Dr. Engel received honorariums from Cerebel for advisory committee membership.
	Randolph W Evans MD Clinical Professor of Neurology Baylor College of Medicine Clinical Associate Professor University of Texas Health Science Center, Houston Editorial Board Member since 1996: Trauma to the Nervous System Disclosures: Dr. Evans received honorariums from Allergan, Amgen, Biohaven, Lilly, Novartis, and Teva for speaking engagements.
	Martin Farlow MD Professor Emeritus Department of Neurology Indiana University School of Medicine Editorial Board Member since 2001: Behavioral Disorders Disclosures: Dr. Farlow received research grant support from AbbVie, Biogen, Boehringer Ingelheim, Eisai, Eli Lilly, Genentech, Roche, Novartis, Suven Life Sciences Ltd, and vTv Therapeutics; fees from Cerecin/Accera, Allergan, Avanir, AZ Therapies, Eli Lilly, Kyowa Kirin Pharma, Longeveron, Medavante, Merck, Neurotrope Biosciences, Proclara, Takeda, and vTv Therapeutics for consultancy, or advisory board/DSMB membership; licensing fees from Elan; and consulting fees from Cortexyme, Green Valley, Regenera, Samumed, Zhejiang Hisun Pharmaceuticals, Cognition Therapeutics, Danone, Eisai, and Otsuka.
	James Goodwin MD Associate Professor of Ophthalmology and Neurology Director, Neuro-Ophthalmology Service University of Illinois at Chicago Founding Editorial Board Member since 1994: Neuro-Ophthalmology Disclosures: Dr. Goodwin has no relevant financial relationships to disclose.
	Francesc Graus MD PhD* Chief of the Department of Neurology of Hospital Clínic, Barcelona Professor of Medicine of the University of Barcelona Senior Consultant at Hospital Clínic, Barcelona Director, Laboratory Clinical and Experimental Neuroimmunology Institut D’Investigacions Biomédiques August Pi I Sunyer Hospital Clinic, University of Barcelona, Spain Editorial Board Member since 2017: Neuroimmunology Disclosures: Dr. Graus has no relevant financial relationships to disclose.
	John E Greenlee MD Professor and Executive Vice Chair of Neurology University of Utah School of Medicine Staff Neurologist George E Wahlen Veterans Affairs Medical Center Founding Editorial Board Member since 1993: Infectious Disorders Disclosures: Dr. Greenlee received consulting fees from Sommers Schwartz for review of medical records.
	Joseph Jankovic MD* Professor of Neurology Director, Parkinson’s Disease Center and Movement Disorders Clinic Distinguished Chair in Movement Disorders Department of Neurology, Baylor College of Medicine Founding Editorial Board Member since 1992: Movement Disorders *Member, Executive Committee Disclosures: Dr. Jankovic received research and training funding from Allergan, F Hoffmann-La Roche, Medtronic Neuromodulation, Merz, Neurocrine Biosciences, Nuvelution, Revance, and Teva and consulting/advisory board honorariums from Abide, Lundbeck, Retrophin, Parexel, Teva, and Allergan.
	Michael V Johnston MD Professor Emeritus of Neurology and Pediatrics Johns Hopkins University School of Medicine Former Chief Medical Officer & Blum Moser Endowed Chair for Pediatric Neurology Kennedy Krieger Institute / Hugo Moser Research Institute Founding Editorial Board Member since 1993: Pediatric Neurology Disclosures: Dr. Johnston has no relevant financial relationships to disclose.
	Howard S Kirshner MD Professor of Neurology, Psychiatry, and Hearing and Speech Sciences Vice Chairman, Department of Neurology Vanderbilt University School of Medicine Director, Vanderbilt Stroke Center Consultant, Vanderbilt Stallworth Rehabilitation Hospital Editorial Board Member since 2017: Behavioral Neurology Disclosures: Dr. Kirshner received fees from Biogen for consulting work.
	Peter J Koehler MD PhD Faculty of Health, Medicine, and Life Sciences Maastricht University Editorial Board Member since 2020: General Neurology Disclosures: Dr. Koehler has no relevant financial relationships to disclose.
	Douglas J Lanska MD FAAN MS MSPH* Honorary Fellow, Department of Neurology University of Wisconsin School of Medicine and Public Health Madison, Wisconsin Medical College of Wisconsin Milwaukee, Wisconsin Professor of Medical Ethics and the Philosophy and History of Medicine Department of Medical Sociology, Healthcare Economics, and Health Insurance I.M. Sechenov First Moscow State Medical University Ministry of Health of the Russian Federation Moscow, Russia Founding Editorial Board Member since 1993: Neuro-Otology and Neurologic Manifestations of Systemic Disease Disclosures: Dr. Lanska has no relevant financial relationships to disclose..
	Steven R Levine MD SUNY Health Science Center, Brooklyn Professor and Vice Chair, Chief of Neurology University Hospital of Brooklyn Associate Dean for Clinical Research and Faculty Development Brooklyn, New York Founding Editorial Board Member since 1994: Cerebrovascular Disorders Disclosures: Dr. Levine has no relevant financial relationships to disclose.
	Rimas V Lukas MD Associate Chief of the Division of Neuro-Oncology Associate Co-Director of the Brain Tumor Institute Associate Professor, Department of Neurology Northwestern University Feinberg School of Medicine Chicago, Illinois Editorial Board Member since 2017: Neuro-Oncology Disclosures: Dr. Lukas received honorariums from Novocure for speaking engagements, honorariums from Novocure for advisory board membership, and research support from BMS.
	Bernard L Maria MD MBA Professor of Pediatrics and Neurology Sidney Kimmel School of Medicine Thomas Jefferson University Editorial Board Member since 2006: Pediatric Neurology Disclosures: Dr. Maria has no relevant financial relationships to disclose.
	Christina M Marra MD Professor of Neurology Vice Chair of Academic Affairs, Neurology Adjunct Professor, Medicine (Infectious Diseases) University of Washington School of Medicine Editorial Board Member since 2019: Infectious Diseases Disclosures: Dr. Marra has no relevant financial relationships to disclose.
	Roger Packer MD Senior VP of Neuroscience Children's National Medical Center Professor of Neurology and Pediatrics George Washington University Washington, DC Editorial Board Member since 2002: Pediatric Neuro-Oncology Disclosures: Dr. Packer received honorariums from AstraZeneca and Novartis as an advisory board member.
	Deric M Park MD Associate Professor of Neurology Director, Medical Neuro-Oncology University of Chicago Editorial Board Member since 2020: Neuro-Oncology Disclosures: Dr. Park has no relevant financial relationships to disclose.
	Harvey B Sarnat MD Professor of Paediatrics, Pathology, (Neuropathology) and Clinical Neurosciences University of Calgary, Cumming School of Medicine Alberta Children’s Hospital Research Institute, Owerko Centre Founding Editorial Board Member since 1994: Developmental Malformations Disclosures: Dr. Sarnat has no relevant financial relationships to disclose.
	Raphael Schiffmann MD Adjunct Professor, Baylor University Director, Institute of Metabolic Disease Baylor Research Institute Editorial Board Member since 2011: Neurodegenerative Disorders in Childhood Disclosures: Dr. Schiffmann received research grants from Amicus Therapeutics, Protalix Biotherapeutics, and Sanofi Genzyme.
	Nina Schor MD PhD* Deputy Director of the National Institute of Neurological Disorders and Stroke National Institutes of Health (NIH) Bethesda, Maryland Editorial Board Member since 2005: Pediatric Neurology *Member, Executive Committee Disclosures: Dr. Schor has no relevant financial relationships to disclose.
	Stephen D Silberstein MD Professor of Neurology Director, Jefferson Headache Center Thomas Jefferson University Founding Editorial Board Member since 1994: Headache Disclosures: Dr. Silberstein receives honorariums from Abbie, Curelator, Ipsen Therapeutics, Lundbeck Biopharmaceuticals, Supernus Pharmaceuticals, and Theranica for consulting. He is also the principal investigator for clinical trials conducted by Amgen, ElectroCore Medical, and Teva.
	Jonathan D Trobe MD Professor of Ophthalmology and Visual Sciences Professor of Neurology University of Michigan Editorial Board Member since 1996: Neuro-Ophthalmology Disclosures: Dr. Trobe has no relevant financial relationships to disclose.
	Louis H Weimer MD Professor of Neurology at CUMC College of Physicians and Surgeons Columbia University Editorial Board Member since 2004: Peripheral Neuropathies Disclosures: Dr. Weimer has received consulting fees from Roche.
	Barry Wolf MD PhD Professor of Pediatrics, Division of Genetics, Birth Defects and Metabolism Ann & Robert H. Lurie Children's Hospital of Chicago Editorial Board Member since 2008: Metabolic Disorders in Childhood Disclosures: Dr. Wolf has no relevant financial relationships to disclose.

Associate Editors

Robert Fekete MD
Associate Professor
Department of Neurology
New York Medical College
Editorial Board Member since 2020: Movement Disorders

Disclosures: Dr. Fekete received consultation fees from Acadia, Acorda, Adamas, Amneal/Impax, Kyowa Kirin, Lundbeck, Neurocrine, and Teva.

Jennifer Friedman MD
Clinical Professor
Department of Neurosciences and Pediatrics
University of California San Diego
Clinical Investigator, Rady Children’s Institute for Genomic Medicine
Editorial Board Member since 2020: Metabolic Disorders in Childhood

Disclosures: Dr. Friedman has no relevant financial relationships to disclose.

James G Greene MD PhD
Associate Professor of Neurology
Divisions of General Neurology and Movement Disorders
Director, Neurohospitalist Program
Associate Chief of Service for Neurology
Emory University School of Medicine
Editorial Board Member since 2013: General Neurology

Disclosures: Dr. Greene has no relevant financial relationships to disclose.

Michio Hirano MD*
Professor and Director
H Houston Merritt Neuromuscular Research Center
Columbia University
Editorial Board Member since 2014: Neuromuscular Disorders
*Member, Executive Committee

Disclosures: Dr. Hirano has no relevant financial relationships to disclose.

Michael J Howell MD
Associate Professor
Vice-Chair, Education and Faculty Affairs
Department of Neurology
University of Minnesota
Medical Director, Sleep Performance Training for Athletes
Editorial Board Member since 2016: Sleep Disorders

Disclosures: Dr. Howell received grant support from Apnex and GE and honorariums from Inspire as a panel member.

AHM Mahbubul Huq MD PhD
Professor
Department of Pediatrics and Neurology
Wayne State University
Editorial Board Member since 2009: Neurodegenerative Disorders in Childhood

Disclosures: Dr. Huq has no relevant financial relationships to disclose.

K K Jain MD
Consultant in Neurology
Basel, SWITZERLAND
Editorial Board Member since 1997: Therapies

Disclosures: Dr. Jain has no relevant financial relationships to disclose.

Matthew Lorincz MD PhD
Professor
University of Michigan
Editorial Board Member since 2010 : General Neurology

Disclosures: Dr. Lorincz of the University of Michigan received honorariums from Alexion for advisory board service.

Victor W Mark MD
Associate Professor of Physical Medicine and Rehabilitation
University of Alabama at Birmingham School of Medicine
Editorial Board Member since 1997: Behavioral Disorders

Disclosures: Dr. Mark has no relevant financial relationships to disclose.

Solomon L Moshé MD
Professor of Neurology, Neuroscience, and Pediatrics
Charles Frost Chair in Neurosurgery and Neurology
Director, Pediatric Neurology
Director of Clinical Neurophysiology
Albert Einstein College of Medicine
Bronx, New York
Editorial Board Member since 2020: Epilepsy

Disclosures: Dr. Moshé received received consulting fees from Pfizer and UCB.

Heather Moss MD PhD
Assistant Professor of Ophthalmology
Stanford University School of Medicine
Editorial Board Member since 2019: Neuro-Ophthalmology

Disclosures: Dr. Moss has no relevant financial relationships to disclose.

C P Panayiotopoulos MD PhD†
Consultant Emeritus in Clinical Neurophysiology and Epilepsy
St Thomas Hospital, London
Editorial Board Member since 2002: Epilepsy

Disclosures: Dr. Panayiotopoulos has no relevant financial relationships to disclose.

Federica Provini MD PhD
IRCCS Istituto delle Scienze Neurologiche di Bologna
University of Bologna
Bologna, ITALY
Editorial Board Member since 2016: Sleep Disorders

Disclosures: Dr. Provini received speakers' fees from Italfarmaco and Pfizer.

Amy A Pruitt MD
Professor of Neurology
University of Pennsylvania School of Medicine
Editorial Board Member since 2018: Neurologic Manifestations of Systemic Disease

Disclosures: Dr. Pruitt has no relevant financial relationships to disclose.

Anthony T Reder MD
Professor of Neurology
University of Chicago
Editorial Board Member since 2000: Neuroimmunology

Disclosures: Dr. Reder received honorariums from Bayer, Biogen Idec, Caremark Rx, Genentech, Genzyme, Novartis, Mallinckrodt, Mylan, Serono, and Teva-Marion for service on advisory boards and as a consultant as well as stock options from NKMax America for advisory work.

Joseph R Siebert PhD
Professor Emeritus, Department of Pathology
University of Washington
Seattle, Washington
Editorial Board Member since 2017: Developmental Malformations

Disclosures: Dr. Siebert has no relevant financial relationships to disclose.

John M Stern MD
Professor of Neurology
Director, Epilepsy Clinical Program
University of California, Los Angeles
Editorial Board Member since 2003: Epilepsy Treatment

Disclosures: Dr. Stern received honorariums from Eisai, Greenwich, SK Life Sciences, and UCB Pharma as an advisor and from Eisai, Greenwich, LivaNova, Neurelis, and UCB Pharma as a lecturer.

Christina Ulane MD PhD
Assistant Professor of Neurology
Director, VC-10 Neurology Resident Clinic
Neurological Institute, Columbia University Medical Center
Editorial Board Member since 2017: Neuromuscular Disorders

Disclosures: Dr. Ulane received a consulting fee and travel expenses from Roche as a meeting consultant.

Aravindhan Veerapandiyan MD
Director , Comprehensive Neuromuscular Program
Director, PPMD Certified Duchenne Care Center
Co-Director, Muscular Dystrophy Association Care Center
Director, Headache Program
Arkansas Childrens Hospital
Assistant Professor of Pediatrics
University of Arkansas for Medical Sciences

Editorial Board Member since 2019: Neuromuscular Disorders

Disclosures: Dr. Veerapandiyan has no relevant financial relationships to disclose.

Shuu-Jiun Wang MD
Deputy Director, Neurological Institute
Taipei Veterans General Hospital
Professor and Chairman, Faculty of Medicine
National Yang-Ming University School of Medicine
Taipei, Taiwan
Editorial Board Member since 2009: Headache

Disclosures: Dr. Wang received consulting fees from Eli Lilly and Novartis for advisory board membership and honorariums from AbbVie as a speaker.

† Deceased

Former Editors
Click to view former Editorial Board members.

MedLink Neurology Editorial Board

MedLink

General

Subscribers

For Faculty